1. Home
  2. PAR vs DAWN Comparison

PAR vs DAWN Comparison

Compare PAR & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$21.53

Market Cap

1.4B

Sector

Miscellaneous

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$10.48

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
DAWN
Founded
1968
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PAR
DAWN
Price
$21.53
$10.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$64.00
$27.56
AVG Volume (30 Days)
1.4M
2.9M
Earning Date
02-27-2026
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$440,451,000.00
$133,672,000.00
Revenue This Year
$30.39
$18.27
Revenue Next Year
$11.91
$48.39
P/E Ratio
N/A
N/A
Revenue Growth
39.88
31.11
52 Week Low
$22.03
$5.64
52 Week High
$72.60
$13.20

Technical Indicators

Market Signals
Indicator
PAR
DAWN
Relative Strength Index (RSI) 20.18 48.32
Support Level $27.35 $11.00
Resistance Level $40.54 $11.84
Average True Range (ATR) 1.98 0.94
MACD -1.17 -0.19
Stochastic Oscillator 0.35 19.94

Price Performance

Historical Comparison
PAR
DAWN

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: